| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |